Suppr超能文献

改善血液流变学对脑血管疾病临床症状的影响。

Effects of ameliorated haemorheology on clinical symptoms in cerebrovascular disease.

作者信息

Walzl M, Schied G, Walzl B

机构信息

Department of Electrobiology, H.E.L.P.-Center General Hospital, University Departments of Graz, Austria.

出版信息

Atherosclerosis. 1998 Aug;139(2):385-9. doi: 10.1016/s0021-9150(98)00080-x.

Abstract

Cerebrovascular disease (CVD) is associated with high fibrinogen levels and lipid fractions leading to an increase of both plasma and whole blood viscosity as well as raised aggregability of blood cells. One important goal in the treatment of cerebral multiinfarct dementia (MID) therefore should be to reduce fibrinogen and lipoproteins and thereby to improve the haemorheological state. The effect of heparin-induced extracorporeal LDL precipitation (H.E.L.P.), a method for safe and immediate reduction of parameters relevant to haemorheology, such as plasma fibrinogen and the lipoproteins, was investigated in 98 patients with MID. All the patients underwent two H.E.L.P. applications within 8 days. The impact of H.E.L.P. on CVD was studied by changes of laboratory data and by evaluation of clinical symptoms before and after treatment. Each H.E.L.P. session caused an immediate, safe and significant reduction of important rheological parameters such as fibrinogen (P < 0.001), whole blood viscosity at high and low shear rate, plasma viscosity and red cell transit time (P < 0.01 each). Also total cholesterol and low density lipoprotein (P < 0.0001 each), lipoprotein (a) (P < 0.003) and the triglycerides (P < 0.0001) had been reduced. The results in laboratory measurement were followed by a statistically significant improved neurologic recovery, represented in the values of the Mathew Scale, the Mini Mental State Examination and the Activities-of-Daily-Living-Test. These results can indicate the importance and influence of haemorheology on clinical symptoms in CVD.

摘要

脑血管疾病(CVD)与高纤维蛋白原水平和血脂成分相关,会导致血浆和全血粘度增加,以及血细胞聚集性增强。因此,治疗脑多发性梗死性痴呆(MID)的一个重要目标应该是降低纤维蛋白原和脂蛋白水平,从而改善血液流变学状态。我们对98例MID患者研究了肝素诱导的体外低密度脂蛋白沉淀法(H.E.L.P.)——一种能安全、快速降低血液流变学相关参数(如血浆纤维蛋白原和脂蛋白)的方法——的效果。所有患者在8天内接受了两次H.E.L.P.治疗。通过治疗前后实验室数据的变化和临床症状评估来研究H.E.L.P.对CVD的影响。每次H.E.L.P.治疗均能立即、安全且显著降低重要的流变学参数,如纤维蛋白原(P < 0.001)、高切变率和低切变率下的全血粘度、血浆粘度以及红细胞通过时间(每项P < 0.01)。总胆固醇和低密度脂蛋白(每项P < 0.0001)、脂蛋白(a)(P < 0.003)以及甘油三酯(P < 0.0001)也有所降低。实验室测量结果之后是神经功能恢复在统计学上的显著改善,这体现在马修量表、简易精神状态检查表和日常生活活动测试的值上。这些结果可以表明血液流变学对CVD临床症状的重要性和影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验